Ignite Creation Date:
2024-05-06 @ 3:32 PM
Last Modification Date:
2025-12-17 @ 2:44 AM
Study NCT ID:
NCT04668300
Status:
None
Last Update Posted:
2025-10-09 00:00:00
First Post:
2020-08-18 00:00:00
Brief Title:
Oleclumab and Durvalumab for the Treatment of Recurrent, Refractory, or Metastatic Sarcoma
Sponsor:
MD Anderson Cancer Center
Organization:
M.D. Anderson Cancer Center
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Refractory Osteosarcoma |
| Metastatic Angiosarcoma |
| Metastatic Dedifferentiated Liposarcoma |
| Metastatic Osteosarcoma |
| Recurrent Angiosarcoma |
| Recurrent Dedifferentiated Liposarcoma |
| Recurrent Osteosarcoma |
| Refractory Dedifferentiated Liposarcoma |
Keywords: